ArticleCancer immunology research2022

Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.

Belén Blanco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.